Amendment to Consulting AgreementConsulting Agreement • September 23rd, 2022 • Prime Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 23rd, 2022 Company IndustryThis Amendment to the Consulting Agreement (the “Amendment”), effective October 22, 2021 (the “Amendment Effective Date”), is made and entered into by and between Prime Medicine, Inc. (the “Company”), and David R. Liu (the “Consultant”).
Amendment to Consulting AgreementConsulting Agreement • January 12th, 2022 • Prime Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 12th, 2022 Company IndustryThis Amendment to the Consulting Agreement (the “Amendment”), effective October 22, 2021 (the “Amendment Effective Date”), is made and entered into by and between Prime Medicine, Inc. (the “Company”), and David R. Liu (the “Consultant”).